RGS5 and ovarian carcinoma: For example, a study by Silini et al. showed that a low level (<1%) of RGS5 fluorescence covered the normal ovary, whereas RGS5 increased to 7.3% coverage in ovarian carcinoma specimens from patient biopsies.